Clinical Trials on Biofilm in Canada
Total 1 results
-
University of British ColumbiaWithdrawn
Sponsors and Collaborators
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Gunkang Pharmaceuticals, Inc
- Korea Otsuka International Asia Arab
- Rivierduinen, Centre for Personality disorders Jelgersma
- University of Applied Sciences Jena
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Foshan Sanshui District People's Hospital
- Lilly PharmaceuticalCompany
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Plethora Solutions Ltd
- Julian Taylor Green
- Oblikue Consulting
- Eurotrials Brasil Consultores Cientificos Ltda
- Paulo Sérgio Gomes Nogueira Borges
- Iyad Naeem Muhammad, PhD
- Sudimplant SAS - Groupe TBR
- S-Biotek Holding ApS
- United States Department of Defense (DOD)
- Arsha Vidya Tirtha
- View Full List
Medical Conditions
- Deformity Flexion
- Chemotherapy-Induced Neutropenia
- Malaria,Falciparum
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Advance Directive Completion
- Serum Albumin Low
- Vibration; Exposure
- Puberty, Delayed
- Immunologically-induced Lung Disease
- Hypothermia Following Anesthesia, Sequela
- Huntington Chorea
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Visual Attention Span Deficit
- Gray Platelet Syndrome
- Testicular Teratoma
- Blepharospasm of Both Eyelids
- Anemia Acute
- Thyroid and Parathyroid Surgery
- Brain Tumor, Primary
- View Full List
Drug Interventions
- Cyanoacrylate
- ABY-035 i.v.
- Sorafenib
- Pegfilgrastim
- Standard medical therapy
- Rovalpituzumab tesirine
- Bimatoprost 0.03% eye drops
- Furmonertinib 160 mg
- Pemetrexed
- Acalabrutinib in combination with VR
- Celecoxib
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Ebselen
- Oxycodone
- S-Adenosyl-Methionine
- F520
- Vosaroxin
- Cytisine
- Mineralocorticoid receptor antagonist
- MMV390048 120mg
- View Full List
CROs by country
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Egypt
- Contract Research Organizations in Estonia
- Contract Research Organizations in Guinea
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Malta
- Contract Research Organizations in Norway
- Contract Research Organizations in South Korea
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Uganda
- Contract Research Organizations in United States
- CRO list by country